Article

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell Immunity

2021-08-20

Abstract excerpt

<title>Abstract</title> <p>T-cell immunity is central for the control of viral infections. CoVac-1 is a peptide-based vaccine candidate, composed of SARS-CoV-2 T-cell epitopes derived from various viral proteins, combined with the toll-like receptor 1/2 agonist XS15 emulsified in Montanide<sup>TM</sup> ISA51 VG, aiming to induce superior SARS-CoV-2 T-cell immunity to combat COVID-19. We conducted a Phase I open-l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dc60024d-005f-5532-9044-15f778bb67c0
DOI: 10.21203/rs.3.rs-820910/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell ImmunityDOI 10.21203/rs.3.rs-820910/v1Read

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencySemantic proximity Read

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsSemantic proximity Read

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsSemantic proximity Read

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccineSemantic proximity Read

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read

T Cell Responses to SARS-CoV-2Semantic proximity Read

Cellular immune response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity Read

A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross- Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 VariantsSemantic proximity Read

Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity Read

Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccinationSemantic proximity Read

T-cell immunity induced by a nonadjuvanted HLA-restricted peptide COVID-19 vaccineSemantic proximity Read